Exclusive-Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
A transaction for Springworks would rank as one of the biggest pharma deals for Merck in recent years and boost its ongoing efforts to build out its cancer treatment pipeline. In 2015, Merck agreed to buy U.S. lab equipment supplier Sigma-Aldrich for $17 billion.
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Asian News International on MSN12d
Merck Foundation CEO, Senator, Dr. Rasha Kelej for the Sixth Year Recognized as one of 100 Most Influential African Women 2024, for the Sixth YearBusinessWire India Accra [Ghana] Mumbai Maharashtra [India] January 31 Senator Dr Rasha Kelej CEO of Merck Foundation and ...
Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the ...
Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...
Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...
Merck CEO Robert Davis said on an earnings call that Gardasil inventory in China "remains elevated at above normal levels," noting that demand for the shot has not recovered to the level the ...
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback